Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Rapidly Progressing Refractory Hodgkin Lymphoma: A Case Report and a Possible Explanation.

Jóna Á, Irsai G, Barna S, Méhes G, Illés Á, Váróczy L.

Case Rep Med. 2016;2016:7698624. doi: 10.1155/2016/7698624. Epub 2016 Jun 26.

2.

Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.

Jóna Á, Miltényi Z, Póliska S, Bálint BL, Illés Á.

PLoS One. 2016 Jun 21;11(6):e0157651. doi: 10.1371/journal.pone.0157651. eCollection 2016.

3.

[Pulmonary alterations in Hodgkin lymphoma].

Jóna Á, Illés Á, Szemes K, Miltényi Z.

Orv Hetil. 2016 Jan 31;157(5):163-73. doi: 10.1556/650.2016.30351. Review. Hungarian.

PMID:
26801361
4.

[Novel treatment options in relapsed and refracter Hodgkin lymphomas].

Illés Á, Jóna Á, Simon Z, Udvardy M, Miltényi Z.

Orv Hetil. 2015 Nov 8;156(45):1824-33. doi: 10.1556/650.2015.30260. Hungarian.

PMID:
26522856
5.

Combined prognostic value of absolute lymphocyte/monocyte ratio in peripheral blood and interim PET/CT results in Hodgkin lymphoma.

Simon Z, Barna S, Miltenyi Z, Husi K, Magyari F, Jona A, Garai I, Nagy Z, Ujj G, Szerafin L, Illes A.

Int J Hematol. 2016 Jan;103(1):63-9.

PMID:
26462809
6.

Prognostic value of interim and restaging PET/CT in Hodgkin lymphoma. Results of the CHEAP (Chemotherapy Effectiveness Assessment by PET/CT) study - long term observation.

Miltenyi Z, Barna S, Garai I, Simon Z, Jona A, Magyari F, Gergely M, Nagy Z, Keresztes K, Pettendi P, Illes A.

Neoplasma. 2015;62(4):627-34. doi: 10.4149/neo_2015_075.

PMID:
25997970
7.

Asenapine in clinical practice: preliminary results from a naturalistic observational study.

Gramaglia C, Rizza MC, Gattoni E, Gambaro E, Di Marco S, Coppola I, Rossi A, Jona A, Imperatori F, Prosperini P, Chieppa N, Binda V, Farruggio S, Grossini E, Zeppegno P.

Riv Psichiatr. 2014 Nov-Dec;49(6):241-6. doi: 10.1708/1766.19122.

PMID:
25668625
8.

Brentuximab vedotin for treating Hodgkin's lymphoma: an analysis of pharmacology and clinical efficacy.

Illés Á, Jóna Á, Miltényi Z.

Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):451-9. doi: 10.1517/17425255.2015.1007950. Epub 2015 Feb 2. Review.

PMID:
25642958
9.

Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.

Jóna Á, Miltényi Z, Ujj Z, Garai I, Szilasi M, Illés Á.

Expert Opin Drug Saf. 2014 Oct;13(10):1291-7. doi: 10.1517/14740338.2014.946901. Epub 2014 Aug 18.

PMID:
25135756
10.

Immunologic pathomechanism of Hodgkin's lymphoma.

Jona A, Szodoray P, Illés A.

Exp Hematol. 2013 Dec;41(12):995-1004. doi: 10.1016/j.exphem.2013.09.014. Epub 2013 Oct 4. Review.

PMID:
24099823
11.

Cinema in the training of psychiatry residents: focus on helping relationships.

Gramaglia C, Jona A, Imperatori F, Torre E, Zeppegno P.

BMC Med Educ. 2013 Jun 21;13:90. doi: 10.1186/1472-6920-13-90.

12.

[Diagnostic difficulties caused by a pulmonary infiltrate].

Simon Z, Jóna A, Miltényi Z, Páyer E, Lieber A, Szilasi M, Illés A.

Orv Hetil. 2012 Jul 8;153(27):1077-81. doi: 10.1556/OH.2012.29404. Hungarian.

PMID:
22759748
13.

Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary.

Miltényi Z, Simon Z, Páyer E, Váróczy L, Gergely L, Jóna A, Illés A.

ISRN Hematol. 2011;2011:810708. doi: 10.5402/2011/810708. Epub 2011 Dec 1.

14.

The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.

Jóna A, Khaskhely N, Buglio D, Shafer JA, Derenzini E, Bollard CM, Medeiros LJ, Illés A, Ji Y, Younes A.

Exp Hematol. 2011 Oct;39(10):1007-1017.e1. doi: 10.1016/j.exphem.2011.07.002. Epub 2011 Jul 20.

15.

[Changing patterns in the clinical, pathological features of Hodgkin lymphoma].

Miltényi Z, Simon Z, Páyer E, Váróczy L, Gergely L, Jóna A, Illés A.

Orv Hetil. 2010 Dec 5;151(49):2011-8. doi: 10.1556/OH.2010.28990. Hungarian.

PMID:
21106481
16.

Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma.

Jona A, Younes A.

Blood Rev. 2010 Nov;24(6):233-8. doi: 10.1016/j.blre.2010.08.003. Epub 2010 Sep 15. Review.

Supplemental Content

Support Center